![]() |
|
|

,




,1
* Unité de Nutrition et dEndocrinologie, Ecole Nationale Vétérinaire, Nantes, France;
Laboratoire des Fonctions Digestives et Nutrition Humaine, Institut National de la Recherche Agronomique, Nantes, France;
** Laboratoire dEtudes des Résidus et des Contaminants dans les Aliments, Ecole Nationale Vétérinaire, Nantes, France; et
Centre de Recherche en Nutrition Humaine, Nantes, France
1To whom correspondence should be addressed. E-mail: lucile.martin{at}vet-nantes.fr.
We previously demonstrated improvements of colonic lesions due to dextran sulfate sodium (DSS) in rats after 7 d of supplementation with resistant starch (RS) type 3, a substrate yielding high levels of butyrate (C4), a colonic cell fuel source. In the present study, we hypothesized that if inflammation is related to decreased C4 utilization by the colonic mucosa, RS supplementation should restore C4 use simultaneously with an increase in the amount of C4 present in the digestive tract. Hence, we compared, in vivo, the cecocolonic uptake of C4 and its oxidation into CO2 and ketone bodies in control and DSS-treated rats fed a fiber-free basal diet (BD) or a RS-supplemented diet. Sprague-Dawley rats (n = 60) were used. DSS treatment was performed to induce acute colitis and then to maintain chronic colitis. After cecal infusion of [1-13C]-C4 (20 µmol in 1 h), concentrations and 13C-enrichment of C4, ketone bodies, and CO2 were quantified in the abdominal aorta and portal vein. Portal blood flow was recorded. During acute colitis, 13C4 uptake and 13CO2 production were lower in DSS rats than in controls. During chronic colitis, DSS rats did not differ from controls. After 7 d of chronic colitis, RS-DSS rats exhibited the same C4 uptake as BD-DSS rats in spite of higher C4 cecocolonic disposal. After 14 d, C4 uptake was higher in RS-DSS than in BD-DSS rats. Thus, the increased utilization of C4 by the mucosa is subsequent to evidence of healing and appears to be a consequence rather than a cause of this RS healing effect.
KEY WORDS: butyrate metabolism colitis rat resistant starch
This article has been cited by other articles:
![]() |
D. J. Law, E. M. Labut, R. D. Adams, and J. L. Merchant An isoform of ZBP-89 predisposes the colon to colitis Nucleic Acids Res., March 3, 2006; 34(5): 1342 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Kien, M. Schmitz-Brown, T. Solley, D. Sun, and W. L. Frankel Increased Colonic Luminal Synthesis of Butyric Acid Is Associated with Lowered Colonic Cell Proliferation in Piglets J. Nutr., January 1, 2006; 136(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ng, R. Barhoumi, R. B. Tjalkens, Y.-Y. Fan, S. Kolar, N. Wang, J. R. Lupton, and R. S. Chapkin The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes Carcinogenesis, November 1, 2005; 26(11): 1914 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Whelan, P. A. Judd, V. R. Preedy, R. Simmering, A. Jann, and M. A. Taylor Fructooligosaccharides and Fiber Partially Prevent the Alterations in Fecal Microbiota and Short-Chain Fatty Acid Concentrations Caused by Standard Enteral Formula in Healthy Humans J. Nutr., August 1, 2005; 135(8): 1896 - 1902. [Abstract] [Full Text] [PDF] |
||||